SCHEMBL230978

SCHEMBL230978

CCCCCCCCC(C)CCCC(C)CCC(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.63
MAPT P10636 1/20 0.60
FFAR4 Q5NUL3 2/20 0.58
FFAR1 O14842 2/20 0.58
GPR84 Q9NQS5 9/20 0.56
PPARG P37231 7/20 0.56
PPARD Q03181 7/20 0.56
PPARA Q07869 7/20 0.56
HDAC11 Q96DB2 5/20 0.56
TSHR P16473 4/20 0.56
PTPN1 P18031 3/20 0.56
ALDH1A1 P00352 2/20 0.56
TLR2 O60603 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
FABP4 P15090 2/20 0.56
SLC22A6 Q4U2R8 1/20 0.56
SLC22A8 Q8TCC7 1/20 0.56
MEN1 O00255 1/20 0.56
ESR1 P03372 1/20 0.56
ALOX15 P16050 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5879104 1.00 ACE2 (0.63) ACE2MAPTFFAR4FFAR1GPR84
SCHEMBL12970997 1.00 ACE2 (0.63) ACE2MAPTFFAR4FFAR1GPR84
SCHEMBL5879052 0.98 MAPT (0.62) ACE2MAPTFFAR4FFAR1GPR84
SCHEMBL2545350 0.98 ACE2 (0.66) ACE2MAPTFFAR4FFAR1GPR84
SCHEMBL1134744 0.98 ACE2 (0.66) ACE2MAPTFFAR4FFAR1GPR84
SCHEMBL25275005 0.98 ACE2 (0.66) ACE2MAPTFFAR4FFAR1GPR84
SCHEMBL13746761 0.98 ACE2 (0.66) ACE2MAPTFFAR4FFAR1GPR84
SCHEMBL16213113 0.98 ACE2 (0.66) ACE2MAPTFFAR4FFAR1GPR84
SCHEMBL8036038 0.98 ACE2 (0.66) ACE2MAPTFFAR4FFAR1GPR84
SCHEMBL2222385 0.98 ACE2 (0.66) ACE2MAPTFFAR4FFAR1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120053661-A Hydrophilic fatty acid complex for preventing, preventing or treating microbial infection, preparation and application thereof 太阳雨林(北京)生物医药有限公司 2025-05-30 CN disclosed
CN-120053660-A Hydrophilic complex for preventing, preventing or treating microbial infection, preparation and application thereof 太阳雨林(北京)生物医药有限公司 2025-05-30 CN disclosed
CN-119855607-A Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, preparation and application 太阳雨林(北京)生物医药有限公司 2025-04-18 CN disclosed
EP-4520348-A1 CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF Sunforest (Beijing) Biopharma Ltd (CN) 2025-03-12 EP disclosed
WO-2023213310-A9 CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF 太阳雨林(北京)生物医药有限公司 2025-02-20 WO disclosed
WO-2023213310-A1 CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF 太阳雨林(北京)生物医药有限公司 2023-11-09 WO disclosed
CN-115607677-A Compound for preventing, preventing or treating microbial infection and preparation and application thereof 太阳雨林(北京)生物医药有限公司 2023-01-17 CN disclosed
CN-114569726-B Compound for preventing, preventing or treating microbial infection and preparation method and application thereof 太阳雨林(北京)生物医药有限公司 2022-10-28 CN disclosed
CN-114788872-A Compound for preventing, preventing or treating microbial infection and preparation and application thereof 太阳雨林(北京)生物医药有限公司 2022-07-26 CN disclosed
CN-114569726-A Compound for preventing, preventing or treating microbial infection and preparation method and application thereof 太阳雨林(北京)生物医药有限公司 2022-06-03 CN disclosed
US-8933131-B2 Intermediates and surfactants useful in household cleaning and personal care compositions, and methods of making the same THE PROCTER & GAMBLE COMPANY (US) 2015-01-13 US disclosed
US-8933131-B2 Intermediates and surfactants useful in household cleaning and personal care compositions, and methods of making the same THE PROCTER & GAMBLE COMPANY (US) 2015-01-13 US disclosed
EP-2523652-A1 INTERMEDIATES AND SURFACTANTS USEFUL IN HOUSEHOLD CLEANING AND PERSONAL CARE COMPOSITIONS, AND METHODS OF MAKING THE SAME The Procter & Gamble Company (US) 2012-11-21 EP disclosed
EP-2508171-A1 Pharmaceutical magnetic nano-particle composition UNIVERSITÄTSKLINIKUM ERLANGEN (DE) 2012-10-10 EP disclosed
US-20120004854-A1 METABOLIC BIOMARKERS FOR OVARIAN CANCER AND METHODS OF USE THEREOF GEORGIA TECH RESEARCH CORPORATION 2012-01-05 US disclosed
WO-2011088089-A1 INTERMEDIATES AND SURFACTANTS USEFUL IN HOUSEHOLD CLEANING AND PERSONAL CARE COMPOSITIONS, AND METHODS OF MAKING THE SAME THE PROCTER & GAMBLE COMPANY (US) 2011-07-21 WO disclosed
WO-2011088089-A1 INTERMEDIATES AND SURFACTANTS USEFUL IN HOUSEHOLD CLEANING AND PERSONAL CARE COMPOSITIONS, AND METHODS OF MAKING THE SAME THE PROCTER & GAMBLE COMPANY (US) 2011-07-21 WO disclosed
US-20110171155-A1 Intermediates And Surfactants useful In Household Cleaning And Personal Care Compositions, And Methods Of Making The Same THE PROCTER & GAMBLE COMPANY 2011-07-14 US disclosed
US-20110171155-A1 Intermediates And Surfactants useful In Household Cleaning And Personal Care Compositions, And Methods Of Making The Same THE PROCTER & GAMBLE COMPANY 2011-07-14 US disclosed
US-20110171155-A1 Intermediates And Surfactants useful In Household Cleaning And Personal Care Compositions, And Methods Of Making The Same THE PROCTER & GAMBLE COMPANY 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171155-A1 Intermediates And Surfactants useful In Household Cleaning And Personal Care Compositions, And Methods Of Making The Same HACD2, DSG1, HACD3 ACE2 4232/4885MAPT 4383/4885FFAR4 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.